XML 44 R37.htm IDEA: XBRL DOCUMENT v3.25.1

Segment Information (Tables)

3 Months Ended

Mar. 28, 2025

Segment Reporting [Abstract]

Revenue, Gross Profit, Gross Profit Margin, Operating Income (Loss), and Depreciation and Amortization Expenses by Reportable Segment

	Three Months Ended March 28, 2025
	Automation Enabling Technologies				Medical Solutions				Total
Revenue	$	123,167			$	110,199			$	233,366
Cost of revenue		62,422				62,036
Amortization of purchased intangible assets		1,359				2,202
Segment gross profit		59,386				45,961				105,347
Research and development and engineering		9,439				13,955
Selling, general and administrative		19,159				14,732
Amortization of purchased intangible assets		2,408				3,146
Restructuring, acquisition, and related costs		(3,109	)			99
Segment operating income		31,489				14,029				45,518
Unallocated costs		—				—				(13,097	)
Interest income (expense), net		—				—				(5,644	)
Other income (expense), net		—				—				(359	)
Income before income taxes	$	31,489			$	14,029			$	26,418

	Three Months Ended March 29, 2024
	Automation Enabling Technologies				Medical Solutions				Total
Revenue	$	117,389			$	113,527			$	230,916
Cost of revenue		60,318				65,182
Amortization of purchased intangible assets		1,569				2,123
Segment gross profit		55,502				46,222				101,724
Research and development and engineering		9,997				13,266
Selling, general and administrative		18,495				13,622
Amortization of purchased intangible assets		2,801				2,949
Restructuring, acquisition, and related costs		279				366
Segment operating income		23,930				16,019				39,949
Unallocated costs		—				—				(14,342	)
Interest income (expense), net		—				—				(8,254	)
Other income (expense), net		—				—				(437	)
Income before income taxes	$	23,930			$	16,019			$	16,916

	Three Months Ended
	March 28,				March 29,
Depreciation and Amortization Expenses	2025				2024
Automation Enabling Technologies	$	5,476			$	5,856
Medical Solutions		7,679				6,597
Unallocated		408				476
Total	$	13,563			$	12,929

	March 28,				December 31,
	2025				2024
Accounts Receivable
Automation Enabling Technologies	$	77,726			$	70,829
Medical Solutions		86,475				80,197
Total accounts receivable	$	164,201			$	151,026
Inventories
Automation Enabling Technologies	$	90,002			$	89,009
Medical Solutions		55,433				55,597
Total inventories	$	145,435			$	144,606
Total segment assets	$	309,636			$	295,632

Schedule of Geographic Revenue

The Company aggregates geographic revenue based on the customer locations where products are shipped to. Revenue by geography was as follows (in thousands):

	Three Months Ended
	March 28,				March 29,
	2025				2024
United States	$	123,646			$	117,081
Germany		28,477				33,181
Rest of Europe		31,781				30,971
China		21,434				17,071
Rest of Asia-Pacific		23,379				27,256
Other		4,649				5,356
Total	$	233,366			$	230,916

Revenue By End Market

The Company primarily operates in two end markets: the medical market and the advanced industrial market. Revenue by end market was approximately as follows:

	Three Months Ended
	March 28,				March 29,
	2025				2024
Medical		55	%			55	%
Advanced Industrial		45	%			45	%
Total		100	%			100	%

X

- Definition

Tabular disclosure of revenue from external customers by end markets.

+ References

No definition available.

+ Details

Name:	novt_RevenueByEndMarketTableTextBlock
Namespace Prefix:	novt_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration